Published October 29, 2013 | Version v1
Journal article

Long term control of a maxillary sinus mucoepidermoid carcinoma with low dose radiation therapy: a case report

  • 1. Department of Radiation Oncology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario (Canada)
  • 2. Department of Otolaryngology - Head and Neck Surgery, University of Toronto, Toronto, Ontario (Canada)
  • 3. Department of Pathology, University Health Network, University of Toronto, Toronto, Ontario (Canada)

Description

Mucoepidermoid carcinoma of the maxillary sinus is a rare malignancy of the head and neck. The location of this tumour near vital structures and its large size at presentation makes surgical resection with negative margins challenging. In incurable cases, relief from symptoms such as epistaxis may be achieved with radiation therapy. We present a case of mucoepidermoid carcinoma of the maxillary sinus that was effectively palliated with a short course of radiation therapy, achieving complete cessation of bleeding, decrease in tumour size, and long term control. We surveyed the literature on mucoepidermoid carcinomas and propose that some tumours may be particularly radiosensitive, benefiting from even short courses of radiation therapy

Availability note (English)

Available from http://dx.doi.org/10.1186/1748-717X-8-251; Available from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3829377

Additional details

Publishing Information

Journal Title
Radiation Oncology (Online)
Journal Volume
8
Journal Page Range
p. 251
ISSN
1748-717X

INIS

Country of Publication
United Kingdom
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
47065882
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
CARCINOMAS; RADIATION DOSES; RADIOTHERAPY; SINUSES
Descriptors DEC
CAVITIES; DISEASES; DOSES; MEDICINE; NEOPLASMS; NUCLEAR MEDICINE; RADIOLOGY; THERAPY

Optional Information

Copyright
Copyright (c) 2013 Vulpe et al.
Notes
PMCID: PMC3829377; PUBLISHER-ID: 1748-717X-8-251; PMID: 24165756; OAI: oai:pubmedcentral.nih.gov:3829377; licensee BioMed Central Ltd.